0001585364S-3ASREX-FILING FEESOrdinary Stock, nominal value 0.001 per share, of Perrigo Company plc00000000 0001585364 2024-09-09 2024-09-09 0001585364 2 2024-09-09 2024-09-09 0001585364 3 2024-09-09 2024-09-09 0001585364 4 2024-09-09 2024-09-09 0001585364 5 2024-09-09 2024-09-09 0001585364 6 2024-09-09 2024-09-09 0001585364 1 2024-09-09 2024-09-09 iso4217:USD
Exhibit 107.1
Calculation of Filing Fee Table
Form
S-3
(Form Type)
Issuer:
Perrigo Company plc
Perrigo Finance Unlimited Company
Guarantors:
Athena Neurosciences, LLC
Chefaro Ireland Designated Activity Company
Elan Pharmaceuticals, LLC
Galpharm Healthcare Limited
Galpharm International Limited
Gr8ness, LLC
L. Perrigo Company
Medgenix Benelux NV
OCE-BIO
BVPerrigo Belgium NV
Perrigo Capital NV
Omega Pharma Innovation & Development NV
Omega Pharma International NV
Omega Pharma Limited
Omega Pharma Trading NV
Omega Teknika Designated Activity Company
PBM Canada Holdings, LLC
PBM Nutritionals, LLC
PBM Products, LLC
Perrigo Americas Holdings, Inc.
Perrigo Company
Perrigo Corporation Designated Activity Company
Perrigo Diabetes Care, LLC
Perrigo Direct, Inc.
Perrigo Europe Invest NV
Perrigo Finance (US) LLC
Perrigo Florida, Inc.
Perrigo Holding NV
Perrigo Holdings Unlimited Company
Perrigo International Finance Designated Activity Company
Perrigo International Holdings II, Inc.
Perrigo International Holdings, LLC
Perrigo International, Inc.
Perrigo Investments, LLC
Perrigo Ireland 1 Designated Activity Company
Perrigo Ireland 10 Unlimited Company
Perrigo Supply Chain International Designated Activity Company
Perrigo Ireland 13 Designated Activity Company
Perrigo Ireland 2 Designated Activity Company
Perrigo Ireland 4 Unlimited Company
Perrigo Ireland 5 Unlimited Company
Perrigo Ireland 6 Unlimited Company
Perrigo Ireland 9 Unlimited Company
Perrigo Management Company
Perrigo Mexico Investment Holdings, LLC
Perrigo New York, Inc.
Perrigo Pharma International Designated Activity Company
Perrigo Pharma Limited
Perrigo Research & Development Company
Perrigo Sales Corporation
Perrigo Science One Designated Activity Company
Perrigo UK Acquisition Limited
PMI Branded Pharmaceuticals, Inc.
Ranir Global Holdings, LLC
Ranir (Holdings) Limited
Ranir, LLC
Wrafton Laboratories Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Debt | Debt Securities of Perrigo Company plc | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | ||||||||||||||||
Debt | Debt Securities of Perrigo Finance Unlimited Company | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | |||||||||||||||||
Debt | Guarantees by Perrigo Company plc of Debt Securities (2) | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | |||||||||||||||||
Debt | Guarantees by Perrigo Finance Unlimited Company of Debt Securities (2) | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | |||||||||||||||||
Equity | Ordinary Stock, nominal value €0.001 per share, of Perrigo Company plc | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | |||||||||||||||||
Equity | Preferred Stock, nominal value of $0.0001 per share, of Perrigo Company plc | Rule 456(b) and Rule 457(r)(1) | (1) | (1) | (1) | (1) | (1) | |||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | ||||||||||||||
Total Offering Amounts | $ — | $ — | ||||||||||||||||||||||
Total Fees Previously Paid | $ — | |||||||||||||||||||||||
Total Fee Offsets | $ — | |||||||||||||||||||||||
Net Fee Due | $ — |
(1) | An indeterminate amount of securities to be offered at indeterminate prices is being registered pursuant to this registration statement. In accordance with Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, the registrant is deferring payment of the registration fee. |
(2) | Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is being paid in respect of the guarantees. The guarantees do not trade separately. |